Physiomics Plc (LON:PYC – Get Free Report)’s stock price shot up 21.3% on Wednesday . The stock traded as high as GBX 1.19 ($0.01) and last traded at GBX 1 ($0.01). 5,343,470 shares changed hands during trading, a decline of 23% from the average session volume of 6,964,461 shares. The stock had previously closed at GBX 0.83 ($0.01).
Physiomics Stock Up 30.3 %
The firm has a 50-day moving average of GBX 0.74 and a two-hundred day moving average of GBX 0.71. The stock has a market capitalization of £2.18 million, a price-to-earnings ratio of -13.83 and a beta of 1.69.
Insider Activity
In related news, insider Peter Sargent bought 459,090 shares of the firm’s stock in a transaction on Thursday, November 7th. The stock was bought at an average price of GBX 1 ($0.01) per share, with a total value of £4,590.90 ($5,660.09). 4.18% of the stock is owned by corporate insiders.
Physiomics Company Profile
Physiomics Plc provides consulting services to pharmaceutical companies in the areas of outsourced quantitative pharmacology and computational biology in the United Kingdom, the United States, and the European Union Switzerland. The company offers modeling, simulation, and data analysis services covering various ranges of oncology research and development using its proprietary Virtual Tumour predictive software.
See Also
- Five stocks we like better than Physiomics
- Short Selling: How to Short a Stock
- SAP’s Strong Momentum: A Bullish Setup for Investors
- ETF Screener: Uses and Step-by-Step Guide
- BlackRock Breaks Records: Why the Stock Still Has Room to Run
- The 3 Best Blue-Chip Stocks to Buy Now
- Duke vs. NRG: Which Energy Stock Will Power Higher Gains?
Receive News & Ratings for Physiomics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Physiomics and related companies with MarketBeat.com's FREE daily email newsletter.